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Abstract
A newly identified virus coronavirus, SARS-CoV-2 caused a worldwide pandemic
named COVID-19. This pandemic caused an interruption in the way medical care was
traditionally delivered to People Living With HIV/AIDS (PLWHA). To meet the ongoing
medical needs of PLWHA, HIV medical care was expanded to telehealth (i.e., telephone calls,
video chat). Telehealth was implemented to keep patients engaged in care and treatment
adherent. This study explores patients’ feelings and attitudes around their HIV care during the
COVID-19 pandemic. A one-time survey was administered to patients who received care at an
outpatient Ryan White HIV/AIDS Program funded HIV clinic in the Southeastern part of the
United States from March-August 2020. The survey items collected demographic information
and explored patients’ thoughts and feelings toward telehealth. There were 137 participants that
completed the survey with the median age of 52, 76% were male, 22% were female, and 48%
identified as African American. For patients who utilized the telehealth option (n=99), 68%
agreed that they would utilize telehealth option for their care if it was offered again in the future.
The main benefit to using telehealth as reported by patients was the ability for telehealth to fit
better with their schedules. There was no significant difference in age of telehealth users. The
results of this study indicate that this telehealth model can be applied to the HIV care continuum
moving forward with participants reporting overall satisfaction with their HIV care during
COVID-19. Telehealth programs in HIV care can improve retention in care and medication
adherence for PLWHA.
Keywords: COVID-19, Ryan White HIV/AIDS Program, PLWHA, HIV, telehealth, adherence
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Chapter 1: INTRODUCTION
Background and Need
South Carolina is a high incident state for the number of new cases of HIV ranking 9th in
the nation (SCDHEC, 2018). As of 2016, there was an estimated 18, 998 people living with
HIV/AIDS in the state of South Carolina (SCDHEC, 2018), representing 0.37% of the total
population living in South Carolina. African Americans are disproportionately affected and the
rate of incidence of new infections have increased by 10% from 2015 to 2016 (SCDHEC, 2018).
With South Carolina being a high incidence state, viral suppression is key in lowering the
number of new cases. Viral suppression is the duplication of the HIV virus in the body which is
achieved by medication adherence and access to care. Research shows that if a person has an
undetected viral load, they will likely not pass the HIV virus onto their sexual partners which can
lead to an AIDS-free generation (Hull & Montaner, 2013).
Prior to Coronavirus 2019 (COVID-19) some health systems adopted a HIV telehealth
model for their rural patients However, telehealth was not a commonly used practice in HIV
care. Three Veteran Administration (VA) health systems found that there was improved HIV
care management when veterans could utilize a telehealth platform (Wicklund, 2019). The
COVID-19 epidemic presented a unique challenge for patients and providers to engage in
medical care. The COVID-19 epidemic caused an immediate interruption in the way HIV care is
delivered all over the U. S. (Mgbako et al., 2020). As a result, telehealth services had to be put
in place to meet the demand of medical care and medication adherence within the HIV infected
populations. COVID-19 has changed the society, economy, and healthcare system which has
caused a rapid adoption of telehealth services and activities to deliver care remotely (Wosik, et
al., 2020). However, previous studies of HIV medical care in-person office visits have shown
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that high quality communication from providers (i.e. active listening, providing feedback) and
strong patient-provider relationship leads to improved outcomes (Mgbako, et al., 2020). Further
research needs to be conducted to determine if this would remain true for virtual telehealth visits.
Macro Policy Implications
According to the Health Resources and Service Administration (HRSA), the National
HIV/AIDS Strategy (NHAS) first proposed in 2010 and updated in 2020 is to end the HIV
epidemic (HRSA Ryan White HIV/AIDS Program, 2020). The four primary goals are to reduce
the number of new HIV infections, increase access to care for people living with HIV (PLWH),
reduce HIV health disparities and health inequities, and achieve more national response to the
HIV epidemic (HRSA Ryan White HIV/AIDS Program, 2020). In alignment with the National
HIV AIDS Strategy, telehealth could be the bridge to assist in ending the HIV epidemic.
Furthermore, telehealth is essential to the healthcare delivery in rural and remote areas that lack
access to adequate health care services and other specialty care (HRSA, 2020). Telehealth use
has expanded over the past decades with traditional models of telehealth involving care delivery
from an originating site from a specialist working at a hub site (HRSA, 2020).
At the onset of the Trump administration the Office of National AIDS Policy and The
Presidential Advisory Council on HIV/AIDS (PACHA) went through a difficult transition.
Several members resigned, quit, or were fired stating that President Trump lacked compassion
for people who were living with HIV/AIDS and the council was deactivated (Finnega, 2019).
The council was reactivated after President Trump proposed $291 million to the federal budget
to ending the HIV epidemic by year 2020 (Finnega, 2019). Simultaneously, President Trump cut
funding for the Department of Health and Human Services, which funds many of the HIV
programs including the Ryan White HIV/AIDS Program. The goal of President Trump’s
10

program was to reduce the number of new HIV infections by 75% within the next five years and
90% by the next decade (Minemyer, 2019). Under President Trump’s leadership, The Centers
for Medicare and Medicaid Services (CMS) expanded access to Medicare telehealth services so
that participants could receive a wider range of services from their healthcare providers without
having to travel to a healthcare facility (Centers for Medicare and Medicaid Services, 2020).
These changes in policy were granted under the President’s emergency declaration as a
temporary and emergency benefit based under the 1135 waiver authority and Coronavirus
Preparedness and Response Supplemental Appropriations Act (Centers for Medicare and
Medicaid Services, 2020).
Micro Policy Implications
The South Carolina Department of Health and Environmental Control (SC DHEC)
STD/HIV division has used the Statewide Coordinated Statement of Need (SCSN) process to
identify the unique issues that South Carolinians face that are at risk for HIV (SCDHEC, 2016).
SC DHEC uses the National HIV/AIDS Strategy goals for 2020 as a benchmark for the SC
HIV/AIDS strategy, 2017-2021 (SCDHEC, 2016). Table 1 illustrates the room for improvement
between 2020 benchmarks and the 2014 SC HIV data.
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Table 1: National HIV/AIDS Strategy Vs. South Carolina HIV/AIDS Continuum Care Data
National HIV/AIDS (NHAS) Strategy
Indicators by 2020

Reduce the number of new HIV diagnoses by at
least 25 percent.
Increase the percentage of people living with HIV
who know their serostatus to at least 90 percent.
Increase the percentage of newly diagnosed
persons linked to HIV medical care within one
month of their HIV diagnosis to at least 85%
Increase the percentage of persons with diagnosed
HIV infection who are retained in HIV medical care
to at least 90%
Reduce the percentage of person in HIV medical
are who are homeless to no more than 5%.
Increase the percentage of persons with diagnosed
HIV-infection who are virally suppressed to at least
80%.

South Carolina HIV Care Continuum Data
CY 2014
773 new infections in 2014
79.66%
75%
54%
Data not available outside of Ryan
White/HOPWA reports.
53%

The SCSN began meeting in late 2015 with representatives from off all the Ryan White
HIV/AIDS Program providers in the state of South Carolina including Housing Opportunities for
Persons living with AIDS (HOPWA) grantees and SC DHEC staff (SCDHEC, 2016). The HIV
Planning Council (HPC) is a combined prevention and care planning body established in 2005
and closely involved in all phases of the SC HIV/AIDS strategy (SCDHEC, 2016). The HPC
consists of 34 members including 17 people living with HIV/AIDS in the state of South
Carolina. South Carolina was one of the first states to combine a care and prevention planning
body. To address access to care concerns, the SC HIV/AIDS strategy proposed an objective to
increase the percentage of newly diagnosed HIV infected persons linked to HIV medical care
within one month of their diagnosis to at least 85% by the end of year 2020 (SCDHEC, 2016).
One of the strategies in this objective is to increase the use of telehealth to decrease barriers to
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care such as transportation by the end of year 2019. An indicator of this success will be the
number of clinics that provide telehealth services (SCDHEC, 2016). The hope desired outcome
is that access to care in all forms will improve adherence to medical care.
The South Carolina Telehealth Alliance (SCTA) is a statewide collaboration of many
organizations across the state to expand telehealth services (South Carolina Telehealth Alliance,
2020). The 2020 SCTA strategic plan includes the eight following objectives: open access, rural
focus, service development, mental health, education and training, SCTA collaboration,
outcomes, and promotion and sustainability. With the arrival of COVID-19 in South Carolina,
many organizations across the state used the opportunity to accelerate and/or establish telehealth
strategic objectives to quickly respond to patient and provider needs (South Carolina Telehealth
Alliance, 2020).
Problem Statement
The onset of COVID-19, facilitated an immediate need to transition from in-person to
telehealth for HIV care (Dandachi, Freytag, & Dang, 2020). As a result of the COVID-19
epidemic, practitioners and providers have rapidly implemented telehealth initiatives in order
provide HIV care and keep patients medically compliant. There have been very little published
studies to ascertain the effects of medical compliance with the use of telehealth as a method for
staying engaged in HIV care. It is vital that telehealth be explored in terms of the patientprovider relationship as previous studies conducted on HIV care have found that the patientprovider relationship is paramount in a HIV infected person remaining in care. Furthermore,
since the onset of the HIV epidemic, rural communities have been plagued with the burden of
traveling more than 30 miles one-way for a doctor’s appointment which has led to noncompliance in many rural communities (Cross, 2016).
13

Population and Study Setting
The setting of this study will be a clinic in the South Eastern United States. This clinic
serves patients from seven counties yet accessible open to any adult (ages 18 and older) that lives
in South Carolina.
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Chapter 2: Literature Review
This chapter explores the literature available on the use of telehealth in HIV care and the
building blocks of survey research. The literature review falls into two main categories: the first
category includes what has been written and studied concerning telehealth and telemedicine
focusing on HIV care and retention in HIV care, the second category includes information on
survey research methods.
Literature Review Methodology
Searches were conducted using relevant academic databases such as Google Scholar,
PubMed, and Medline. PubMed was determined to be the most reliable and updated information
on the subject. An initial review of the literature included an extensive search of telemedicine
and telehealth care in HIV. However, with the onset of the COVID-19 epidemic the literature
review became ongoing as treatment and disease state of the COVID-19 virus are everchanging.
The initial rounds of literature search included key terms such as: telehealth in HIV care,
telemedicine in HIV care, and HIV care in rural communities. This allowed the researcher to
focus on research that was conducted prior to the onset of COVID-19. With the shift to focusing
on COVID-19 and HIV care, the literature search included the following key terms: COVID-19
and telehealth and COVID-19 and HIV and telehealth. The COVID-19 and telehealth literature
search yielded nine results between March 2020 and August 2020.
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Telemedicine and Telehealth in HIV Care
Telemedicine and telehealth have been used to engage patients in healthcare at a distance.
Although both terms have been used interchangeably, for administrative purposes telemedicine
and telehealth have different meanings (Chaet, Clearfield, Sabin, & Skimming, 2017).
Telemedicine is the exchange of information remotely from one site to another by electronic
means for the purposes of patient care (Qubty, Patniyot, & Gelfand, 2018). CMS also defines
telemedicine, for the purposes of reimbursement, as a “two way” real time communication
between patient and practitioner at a distant site (Chaet, Clearfield, Sabin, & Skimming, 2017).
HRSA defines telehealth as involving telecommunications and electronic technologies to
“support and promote long distance clinical health care, patient and professional health-related
education and public health and administration” (Chaet, Clearfield, Sabin, & Skimming, 2017).
Prior to the onset of COVID-19, many organizations and places around the globe have initiated a
telehealth initiative as it relates to HIV care. With the Veterans Health Administration (VHA)
being the largest provider of HIV care in the United States, there have been several opportunities
to conduct studies on telehealth programs (Ohl M. E., et al., 2019). The VHA has a progam
called the Telehealth Collaborative Care for Rural HIV patients that connects them virtually with
HIV/AIDS healthcare providers (RHIhub, 2002-2019). Devi and colleagues (2015) evaluated
the utilization of mobile phone technology for treatment adherence and prevention of HIV/AIDS
and tuberculosis (TB) patients of already published studies. Out of the 90 articles published,
they found that mobile phone technology is an effective tool for HIV/AIDS and TB long term
with most of the studies being done in underdeveloped countries. When looking at different
health systems who have decided to develop a telehealth model for HIV infected patients, VHA
has taken a leadership role by investing in telemedicine to serve the 20% of veterans who reside
in rural areas (Saifu, et al., 2012). Saifu and colleagues (2012) evaluated the impact of the HIV
16

and Hepatitis C telemedicine model on outcomes in the rural VHA populations. Their research
found that out of the 43 patients who participated in 94 telemedicine visits and 128 in-person
visits, telemedicine visits garnered improved access, high patient satisfaction, and reduction in
health visit-related times. Another study of three VHA health systems found that there was
improved HIV care management when veterans could utilize a telehealth platform (Wicklund,
2019). This study noted that while only 13% of VHA patients used the telehealth services when
available, there was still improved care. Additionally, it was found that increased monitoring of
viral load improved viral suppression (Wicklund, 2019). Research found that people who live
far from infectious disease specialty clinics are more likely to use primary care for their HIV care
(Ohl M. E., Richardson, Kaboli, Perencevich, & Vaughn-Sarrazin, 2014). Consequently, a VHA
study done to ascertain the impact of availability of HIV specialty clinics telehealth programs,
found that the availability of telehealth programs did in fact improve HIV viral suppression (Ohl
M. E., et al., 2019). Specialty clinics would benefit from using telehealth to provide care over
distance and programs to coordinate “shared care” with distant primary care providers (Ohl M.
E., Richardson, Kaboli, Perencevich, & Vaughn-Sarrazin, 2014).
Medical Advocacy and Outreach (MAO) is a community-based organization (CBO) that
provides care in rural Alabama (RHIhub, 2002-2019). Services include secure video chat with
primary care providers. The Louisiana Public Health Information exchange (LaPHIE) is another
example of a rural telehealth initiative (RHIhub, 2002-2019). LaPHIE is an exchange that
healthcare providers and organizations are using to share health information on a secure network.
The network links providers electronic medical records (EMRs) with state health surveillance data
that is used to diagnose, monitor, and treat a variety of chronic conditions to include HIV and
Hepatitis C. In all of the above mentioned telehealth examples retention in care was improved.
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As result of telehealth being the main source of HIV care at this time due to COVID-19, retention
in care will prove to be a benchmarker for success in HIV care during this pandemic.
A quantitative study examined the rapid implementation of a telehealth program at a HIV
clinic for adolescents and young adults in San Francisco (Barney, Buckelew, Mesheriakova, &
Raymond-Flesch, 2020). Telehealth visits increased from 0 to 96% which was comparable with
the in-person visits from the previous year. However, further research would need to be done to
ascertain outcomes on confidentiality, quality of care, and health disparities. The first 30 days of
a rapid telehealth scale-up in response to COVID-19 included an adolescent HIV clinic found
that there was an 82% appointment completion rate in patient visits (Wood, et al., 2020).
As with the previous study, future studies will need to be conducted to look at health
disparities within the HIV infected populations.
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Chapter 3: Methodology
Telehealth Intervention Development
In March of 2020 a virtual telehealth model was developed to continue provide the same
level of care prior to the onset of the COVID-19 virus. Initially, patients were provided the
option to see their medical provider on the following video platforms: Facetime (iPhone app),
Google Duo (Android app), Doxy (a HIPPA secured platform), or Zoom. In May of 2020, Zoom
was removed as video platform option. If a patient was uncomfortable with any of the previous
video platforms, they could opt for a telephone call or an in-person office visit. A week prior to
a scheduled medical visit, a case manager contacted the patient to ascertain their choice for the
medical appointment. Regardless of the platform chosen, patients’ virtual medical visits were
treated like the in-person visit format. A nurse contacted the patient by telephone 15 minutes
prior to their scheduled appointment to perform a virtual check-in. After the check-in process
was complete, the nurse provided the patient instructions on how their medical provider would
be contacting them for their visit. Preliminary discussions with the medical director of the clinic
suggested that the elderly population did not have good success utilizing telemedicine based on
the technological difficulties faced during virtual medical visits; however, the younger
population seem to better adapt to the use of telehealth. Additionally, the provider felt that
moving forward it would be best to have at least one in-person visit a year so that a connection is
established or remains between client and provider.

Research Question
This study will explore if a HIV telehealth model utilized during the COVID-19 epidemic
for a HIV infected population at a Ryan White HIV/AIDS Program clinic is effective and can
this model be applied across the HIV care continuum moving forward. This research question
aligns with the access to care goal of the National HIV/AIDS Strategy.
19

Research Design
For the purposes of this study, “telehealth” will be the term used to describe the type of
care that was provided. This will be a survey study to measure patients experience around
telehealth care since the onset of COVID-19. Patients were asked to complete a survey in effort
to gain insight on patient experience. A goal of this survey was to understand patients’
experience with the clinic and to continue the same level of HIV care prior to the onset of
COVID-19. This data was analyzed to understand areas of improvement within the current
telehealth model being utilized.
Study Population
A random sample of every actively enrolled patient that opted to accept mail or email at
initial intake was asked to complete a survey. Patients who had a valid email address were sent
an electronic REDCap link (n=391). In cases where patients provided duplicate or unclear
emails, they were asked to complete a pen/paper survey by mail (n=8).
Instrument Development
Surveys are frequently used in telehealth research to ascertain patient’s satisfaction,
experience, and attitudes when it comes to virtual care (Langbecker, Caffery, Gillespie, & Smith,
2017). When conducting survey research, it is best practice to select a previous validated
instrument and conduct a literature review of the current research to choose appropriate
questions (Langbecker, Caffery, Gillespie, & Smith, 2017). Qubty, Parniyot, & Gelfand (2018)
prospective survey conducted on pediatric patients and their families concerning telemedicine
visits, utilized a Cisco WebEx platform. Their survey included 12 questions related to patient
satisfaction based on a 5-point Likert scale. The researchers did not how these questions were
developed. The specific questions were excluded, but rather a table with patient and family
comments regarding their telemedicine visits were included (Qubty, Patniyot, & Gelfand, 2018).
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Dandachi and colleagues (2020) conducted a survey to gauge patients’ attitudes towards their use
of telehealth in an HIV clinic in Houston. The researchers found an overall positive response to
the use of telehealth with patients reporting a better work/life balance, reduction in travel time,
and more privacy with the visit. There was some concern with patients feeling they would not be
able to adequately express themselves, the safety of their personal information, and concerns
with not having an actual physical exam (Dandachi, Freytag, & Dang, 2020). The survey was
developed based on review of the literature and validated questionnaires (Dadanchi, Bang,
Lucari, Teti, & Giordano, 2020). Questions were written at a sixth-grade reading level and
cognitive one-on-one interviews were used to ensure comprehension. The 5-point Likert scale
was used to weigh the questions from very unlikely to very likely, never to always, strongly
agree to strongly disagree, and extremely concerned to not at all concerned. The ten-item
questionnaire included questions about acceptability of telehealth, benefits of telehealth for HIV
care, and concerns about telehealth for HIV care. In reviewing University of Rochester’s
Telemedicine and Non-Telemedicine visit experience interview guide, similar questions were
utilized on a 5-point Likert scale (University of Rochester, 2011).
With broadband capability being a barrier faced in many rural areas of South Carolina, a
key informant interview was done prior to COVID-19 to ascertain providers’ thoughts around
access to HIV medical telehealth services to improve medical compliance and medication
adherence in rural South Carolina. Prior to administering the survey, a test run was conducted
and sent out to the clinic team to ensure the questions were understandable and elicited relevant
data. A key informant interview coupled with provider one-on-one interviews, the program
administrator, and the literature review was the baseline items used to develop survey questions.
To identify a patient experience instrument, a literature search was conducted to assess the
21

availability of validated instruments. Various validated instruments were utilized to assist in the
development of this survey instrument (Table 2).
Table 2: Survey Development Tool
Source

Baseline Item

Category/Type

(Dadanchi, Bang,
Lucari, Teti, &
Giordano, 2020)
(Dadanchi, Bang,
Lucari, Teti, &
Giordano, 2020)

Age/Race/Zip Code

Demographic

If you can use live
video call to see and
talk to your doctor
instead of coming to
clinic appointments,
how often would you
use it?
“the elderly
population did not
have good success
utilizing telemedicine
based on the
technological
difficulties faced
during virtual
medical visits;
however, the younger
population seem to
better adapt to the use
of telehealth”
This service will help
me because it will fit
better with my
schedule.
The service will be
good for me because
no will see me at the
HIV clinic.

Access

1. During COVID-19,

Communication

2.

Which virtual
platform did you
use most often?

Comfort

3.

Virtual visits were
better for my
schedule

Effectiveness

4.

The virtual visit
provided me the
comfort and
confidentiality
needed for my
medical
appointments

“perception questions

Effectiveness

5. The quality of the

Provider Interview

(Dadanchi, Bang,
Lucari, Teti, &
Giordano, 2020
(Dadanchi, Bang,
Lucari, Teti, &
Giordano, 2020

Program Manager

about the quality of the
visit and length of the
appointment”
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Need’s Assessment
Survey Item
Age/Race/Zip Code

how often did you
use the virtual visit
option?

visit and length of
the visit was to my
satisfaction

(Mgbako et al.,
2020).

Key Informant
Interview

Becevic et al.

HIV medical care in- Communication
person office visits
have shown that high
quality
communication from
providers (i.e. active
listening, providing
feedback) and strong
patient-provider
relationship leads to
improved medical
and medication
adherence
“The only thing I
Access
would be concerned
about was if patients
would have access to
the telehealth
materials all the way
in a rural area.”
I would use telehealth Future Adoption
to have my doctor see
me again

6.

I felt a genuine
connection to my
provider during my
virtual visit

7.

I had enough data
on my phone or
access to the
internet to
successfully
complete my virtual
visit

8.

If I had a choice, I
would you use
telehealth again in
the future

Survey Instrument
Survey items shown in Table 3 were administered to patients to collect information on
demographics, feelings around access, communication, comfort, effectiveness, and future
adoption of telehealth services. Patients were asked: “How often did you use the virtual visit
option? Reponses were recorded as categorical variables: (1) never, (2) rarely, (3) some of the
time, (4) most of time, and (5) always, or (1) strongly agree, (2) somewhat disagree (3) neutral
(4) somewhat agree, and (5) strongly agree. The survey also included the preferred type of
telehealth visit if used.
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Table 3: Survey Instrument Tool
Age:
Sex: Male
Female
Ethnicity: African American

Zip Code:

Transgendered
Gender Binary
Hispanic Non-Hispanic-White Asian

Other
Another Race

Thinking about your time during COVID-19 ONLY:
1. How often did you use the virtual visit option?
a. 1. Never
b. 2. Rarely
c. 3. Some of the time
d. 4. Most of the time
e. 5. Always
2. Which virtual platform did you use most often?
a. 1.None
b. 2. Doxy
c. 3. Facetime
d. 4. Google Duo
e. 5. Telephone Call
Please read through the following statements and decide how much you either agree or disagree with each.
3.

4.

5.

6.

7.

8.

Virtual visits were better for my schedule
a. 1. Strongly Disagree
b. 2. Somewhat Disagree
c. 3. Neutral
d. 4. Somewhat Agree
e. 5. Strongly Agree
The virtual visit provided me the comfort and confidentiality needed for my medical appointments
a. 1. Strongly Disagree
b. 2. Somewhat Disagree
c. 3. Neutral
d. 4. Somewhat Agree
e. 5. Strongly Agree
The quality of the visit and length of the visit was to my satisfaction
a. 1. Strongly Disagree
b. 2. Somewhat Disagree
c. 3. Neutral
d. 4. Somewhat Agree
e. 5. Strongly Agree
I felt a genuine connection to my provider during my virtual visit
a. 1. Strongly Disagree
b. 2. Somewhat Disagree
c. 3. Neutral
d. 4. Somewhat Agree
e. 5. Strongly Agree
I had enough data on my phone or access to the internet to successfully complete my virtual visit
a. 1. Strongly Disagree
b. 2. Somewhat Disagree
c. 3. Neutral
d. 4. Somewhat Agree
e. 5. Strongly Agree
If I had a choice, I would you use telehealth again in the future
a. 1. Strongly Disagree
b. 2. Somewhat Disagree
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c.
d.
e.

3. Neutral
4. Somewhat Agree
5. Strongly Agree

Data Analyses Approach
Descriptive statistics for variables of interest was used to categorize and examine patient
experiences, utilization, and preferences. In addition, results were stratified by telehealth
platform and zip code of residence to explore differences by modality and geographic location.
The Institutional Review Boards for the Medical University of South Carolina and study hospital
approved the study protocol.
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Chapter 4: RESULTS

Between November 2020 and January 2021, 399 participants were sent surveys. Of the
399 surveys sent out, eight were by mail and 391 were sent electronically via email using a
REDCap as the survey instrument. Out of the 399 surveys, four participants completed the
questionnaire by mail and 133 participants completed the questionnaire electronically using
REDCap, yielding a 34% response rate (Table 4). There were three incomplete surveys that
were excluded from the overall results.

Table 4: Survey Response Rate

Complete
Total

Mailed
4
8

Redcap
133
391

Response
Rate
34.34%

Total
137
399

Out of the 137 completed responses, the age range was 20-72 years, with a standard deviation of
12 years. The median age of participants was 52 years. The majority of the participants were
male (75%) and identified as African-American (48%) or Non-Hispanic White (46%) (Table 5).
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Table 5: Demographics

Variables

n

Demographics
Age
Sex

Male
Female
Transgendered
Gender Binary
Other
Total
Race/Ethnicity
African-American
Hispanic
Non-Hispanic, White
Asian
Another Race
Total

Mean ± SD

137

51 ± 12.1
Percentage (%)

104
30
1
1
1
137

75.9
21.9
0.73
0.73
0.73
100

66
4
63
2
2
137

48.1
2.9
45.9
1.5
1.5
100

Among the participants who completed the survey, 28% responded that they never used
the virtual visit option and 72% of respondents reported using the virtual visit option at least
once (Figure 1). Focusing on the 72% that used the telehealth option at least once for care,
N=99, telephone calls (47%) was the most preferred virtual platform followed by FaceTime
(26%). Many participants somewhat agreed (32%) or strongly agreed (33%) that virtual visits
were better for their schedule.
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Figure 1: Rate of Telehealth Use
1. How often did you use the virtual visit option?
Always

8.8%

Most of the time

11.7%

Some of the time

23.4%

Rarely

28.5%

Never

27.7%

0%

5%

10%

15%

20%

25%

Percent (N=137)

Over half of the participants (65%) agreed that virtual visits provided them with the
confidentiality needed for their medical appointments. This allows patients to avoid the stigma
of being seen in a HIV clinic as a benefit to telehealth services. We found that once participants
were able to move pass the scheduling issues associated with telehealth visits, with only 33%
strongly agreeing that the virtual visit option was better for their schedules, on average
participants liked having telehealth as an option for care. Only 6% were concerned about
overuse of internet data or internet service on their phones. Nearly 67% of participants reported
that they felt a genuine connection to their provider during their virtual visits (Figure 2). Overall,
68% of respondents if given an option would use telehealth again in the future (Figure 3).
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Figure 2: Q6 Results
6. I felt a genuine connection to my provider during my virtual visit.
Strongly Agree

45.5%

Somewhat Agree

22.2%

Neutral

24.2%

Somewhat Disagree

5.1%

Strongly Disagree

3.0%

0%

10%

20%

30%

Percent (N=99)
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40%

Figure 3: Q8 Results
8. If I had a choice, I would use telehealth again in the future.
Strongly Agree

46.5%

Somewhat Agree

21.2%

Neutral

19.2%

Somewhat Disagree

5.1%

Strongly Disagree

8.1%

0%

10%

20%

30%

40%

Percent (N=99)

Results by Platform
We compared the 99 participants who reported that they utilized the telehealth option
with the type of virtual platform used across six questions. Overall patients preferred telephone
call over all available platforms (46%), followed by Facetime (26%) (Figure 4).
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Figure 4: Telehealth Users by Platform
2. Which virtual platform did you use most often?
Telephone Call

47.5%

Google Duo

4.0%

Facetime

26.3%

Doxy

21.2%

None

1.0%

0%

10%

20%

30%

40%

50%

Percent (N=99)

We evaluated questions 3-8 when comparing the various platforms used. Participants most
commonly chose “strongly agree” across questions 3-8 that used Doxy as their preferred method
when compared to Facetime, Google Duo, or telephone calls. Regarding confidentiality 52% of
participants strongly agreed that Doxy gave them the confidentiality needed for their
appointment followed by Facetime users who agreed at 50%. In looking at quality and length of
visit, Doxy had the highest rate of satisfaction overall at 62%. Provider connection saw that
Doxy provided the greater connection at 52% followed by Facetime at 50% and telephone calls
at 45%.
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Doxy users reported more success with phone data usage and internet connection at 71%. For
patients who strongly agreed that they would use virtual visit as an option in the future Doxy
users reported 57%, followed by Facetime and telephone calls at 46%.

Results by Distance
There was a total of 40 reported zip codes by participants. Out of the 99 who indicated
that they utilized the virtual visit option, they lived between 0-143 miles away from the clinic,
with a standard deviation of 26 miles. The 38 participants that reported never using the
telehealth visit as an option lived between 0-129 miles away from the clinic, with a standard
deviation of 30 miles. Both groups had a median of 17 miles. There was no association with
distance when comparing the participants who used the telehealth option visit, versus those who
did not. Both groups had an average distance of about 25 miles (Figure 5).
Figure 5: Participants by Distance

125

Distance (in miles)

100

75

50

25

0
No

Yes

Telehealth Use
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When evaluating the participants who live in the same zip code as the clinic, 85% still
chose to utilize the virtual visit option at least once. Of the 99 respondents who chose the virtual
visit as an option, the majority lived between 11-20 miles away from the clinic and 39% of them
strongly agreed that virtual visits were better for their schedules. Only half of the patients living
over 40 miles from the clinic agree that virtual visits are better for their schedules. Of the
patients that live closer to the clinic, most of them disagree that virtual visits are better for their
schedule compared to the participants that live farther away from the clinic. Most of the
participants that live an average of at least 16 miles away from the clinic strongly agree that they
would utilize telehealth in the future. Telehealth users who lived more than 10 miles away from
the clinic (Figure 6) were more likely to agree that virtual visits were better for their schedules
compared to telehealth users who lived less than 10 miles away from clinic (p=0.0237).
Figure 6: Distance by Q3
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Chapter 5: Conclusion
Discussion of Results
This study indicates an overall positive experience when it comes to the use of telehealth
as an option for PLWH with more than half of the participants using the virtual visit option at
least once. Furthermore, almost half of the participants agreed that they would use the virtual
visit option again if offered in the future. There is not a significant difference in the average age
of participants who used telehealth (50 years old) compared to those who did not (53 years old).
Previous provider interviews indicated that older patients were more likely not to use the
telehealth option; however, this study indicates no significant difference. In this study, phone
data and access to the internet did not present as a barrier to patients accessing telehealth
services. Based on previous research in HIV care, the provider-patient relationship is vital to
HIV infected populations remaining engaged in care (Mgbako, et al., 2020). Notably, over half
of the patients reported a genuine connection with their provider, which is vital to PLWH
remaining engaged in care. It appears that patients’ decision to use telehealth is based on if it
worked better for their schedules as there was a significant finding based on distance for patients
that lived more than 10 miles away from the clinic.
As a result of the COVID-19 epidemic continuing to be an ongoing public health crisis,
research should be a continuum as participants’ thoughts and attitudes may change pending the
length of this epidemic. Additionally, telehealth needs to be evaluated in greater detail for
people living in rural communities. While this study did factor in zip codes, most of the
respondents lived within 11-20 miles of the clinic which is not an accurate indication of the
patients living in the rural populations that surround the clinic.
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Limitations
There are several limitations to this study. First, this study was limited to a single clinic
in the South Eastern part of the United States; therefore, the results of this study may not be
generalizable to other regions or patient populations. Second, the Likert scale used for the
purposes of this study included options strongly disagree, somewhat disagree, neutral, somewhat
agree, and strongly agree. However, the more commonly used Likert scale options include,
strongly disagree, disagree, neutral, agree, and strongly agree. This difference may have caused
the reader some ambiguity in their responding to the survey. Third, the intent of this survey was
to measure patients’ experiences who are case managed and seen by the medical providers of this
clinic. However, three respondents of the survey see a medical provider outside of the respective
clinic that was being measured but are case managed by the clinic being measured. As a result
of the survey’s respondents being anonymous, those three respondents were included in the
overall results of the survey. Finally, the survey relied on patient’s self-report and actions. For
this reason, the accuracy of the above question may be limited due to the respondents’
misinterpretation or social desirability to answer the questions (Shi, 2008).

Conclusion
This study provides the foundation to explore the utilization of telehealth for HIV care
management. The lessons learned are valuable, as the COVID-19 pandemic may forever change
health care and the way it is delivered. For some time, HIV telehealth has been considered as an
option to keep patients engaged in care and assist in medication management. However, the
COVID-19 pandemic forced the upstart of telehealth and the way that it is conceptualized. The
results of this study indicate that this telehealth model can be applied to the HIV care continuum
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moving forward with participants reporting overall satisfaction with their HIV care during
COVID-19. This study is just a start; however, as we move forward in this new era of medical
care, this topic will need continual revision and refinement to lead us towards an AIDS free
generation. This telehealth model can be applied to HIV telehealth care moving forward.
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